Age and gender-specific hepatitis C continuum of care and predictors of direct acting antiviral treatment among persons who inject drugs in Seattle, Washington

Geographically Focused Collocated Hepatitis C Screening and Treatment in Los Angeles’s Skid Row

(2020) Trista Marie Benitez et al.   DIGESTIVE DISEASES AND SCIENCES

HCV Testing and Treatment in a National Sample of US Federally Qualified Health Centers during the Opioid Epidemic

(2020) Sabrina A. Assoumou et al.   JOURNAL OF GENERAL INTERNAL MEDICINE

Hepatitis C Treatment Uptake among People who Inject Drugs in the Oral Direct‐Acting Antiviral Era

(2020) Oluwaseun Falade‐Nwulia et al.   LIVER INTERNATIONAL

Psychosocial Factors and the Care Cascade for Hepatitis C Treatment Colocated at a Syringe Service Program

(2020) Daniel Winetsky et al.   JOURNAL OF INFECTIOUS DISEASES

Disparities in uptake of direct-acting antiviral Therapy for Hepatitis C among people who inject drugs in a Canadian setting

(2019) M. Eugenia Socías et al.   LIVER INTERNATIONAL

Intensive Models of Hepatitis C Care for People Who Inject Drugs Receiving Opioid Agonist Therapy

(2019) Matthew J. Akiyama et al.   ANNALS OF INTERNAL MEDICINE

Treatment cascade for hepatitis C virus in young adult people who inject drugs in San Francisco: Low number treated

(2019) Meghan D. Morris et al.   DRUG AND ALCOHOL DEPENDENCE

Hepatitis C treatment uptake and response among human immunodeficiency virus/hepatitis C virus-coinfected patients in a large integrated healthcare system

(2019) Jennifer O Lam et al.   INTERNATIONAL JOURNAL OF STD & AIDS

Outcomes of Treatment for Hepatitis C in Primary Care, Compared to Hospital-based Care: A Randomized, Controlled Trial in People Who Inject Drugs

(2019) Amanda J Wade et al.   CLINICAL INFECTIOUS DISEASES

A co-located continuity clinic model to address healthcare needs of women living unhoused with opioid use disorder, who engage in transactional sex in north Seattle

(2019) Jenell Stewart et al.   SEXUALLY TRANSMITTED DISEASES

Increases in Acute Hepatitis C Virus Infection Related to a Growing Opioid Epidemic and Associated Injection Drug Use, United States, 2004 to 2014

(2018) Jon E. Zibbell et al.   AMERICAN JOURNAL OF PUBLIC HEALTH

Efficacy of Glecaprevir/Pibrentasvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2, 4, 5, or 6 Infection Without Cirrhosis

(2018) Tarik Asselah et al.   Clinical Gastroenterology and Hepatology

Hepatitis C virus treatment as prevention in an extended network of people who inject drugs in the USA: a modelling study

(2018) Alexei Zelenev et al.   LANCET INFECTIOUS DISEASES

Glecaprevir–Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection

(2018) Stefan Zeuzem et al.   NEW ENGLAND JOURNAL OF MEDICINE

Hepatitis C Treatment Outcomes for People Who Inject Drugs Treated in an Accessible Care Program Located at a Syringe Service Program

(2018) Benjamin J Eckhardt et al.   Open Forum Infectious Diseases

Hepatitis C continuum of care and utilization of healthcare and harm reduction services among persons who inject drugs in Seattle

(2018) Judith I. Tsui et al.   DRUG AND ALCOHOL DEPENDENCE

Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials

(2017) Ira M. Jacobson et al.   GASTROENTEROLOGY

A Decline in HIV Testing Among Persons Who Inject Drugs in the Seattle Area, 2004–2015

(2017) Richard D. Burt et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Glecaprevir plus pibrentasvir for chronic hepatitis C virus genotype 1, 2, 4, 5, or 6 infection in adults with compensated cirrhosis (EXPEDITION-1): a single-arm, open-label, multicentre phase 3 trial

(2017) Xavier Forns et al.   LANCET INFECTIOUS DISEASES

Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection

(2017) Marc Bourlière et al.   NEW ENGLAND JOURNAL OF MEDICINE

Elbasvir–Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy

(2016) Gregory J. Dore et al.   ANNALS OF INTERNAL MEDICINE

A systematic review of community based hepatitis C treatment

(2016) Amanda J. Wade et al.   BMC INFECTIOUS DISEASES

Race and Gender Differences in the Use of Direct Acting Antiviral Agents for Hepatitis C Virus

(2016) Fasiha Kanwal et al.   CLINICAL INFECTIOUS DISEASES

Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection

(2015) Graham R. Foster et al.   NEW ENGLAND JOURNAL OF MEDICINE

Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection

(2015) Jordan J. Feld et al.   NEW ENGLAND JOURNAL OF MEDICINE

Diagnostics for respondent-driven sampling

(2014) Krista J. Gile et al.   JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY

Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection

(2014) Nezam Afdhal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Elimination of Hepatitis C Virus Infection Among People Who Inject Drugs Through Treatment as Prevention: Feasibility and Future Requirements

(2013) J. Grebely et al.   CLINICAL INFECTIOUS DISEASES

Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals

(2013) Natasha K. Martin et al.   HEPATOLOGY

Hepatitis C virus control among persons who inject drugs requires overcoming barriers to care

(2013) Marija Zeremski   WORLD JOURNAL OF GASTROENTEROLOGY

Comparative Profiles of Men and Women with Opioid Dependence: Results from a National Multisite Effectiveness Trial

(2011) Sudie E. Back et al.   AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE